Device type · KRD
Device, Vascular, For Promoting Embolization
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
KRD
Cardiovascular
Device class
Class II
FDA decisions since 2015
68
510(k), De Novo and PMA
Adverse event reports
1,628
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Device, Vascular, For Promoting Embolization
- Product code
- KRD
- Device class
- Class II
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.3300
- Specialty
- Cardiology, Interventional Cardiology
- FDA record
- Classification database entry for KRD
Latest FDA decisions
The 8 newest of 68 since 2015.
K262798 · Decided Oct 6, 2026 · 60 days after receipt
Device type: Device, Vascular, For Promoting Embolization (KRD) · Cardiology
Suzhou Haowei Medical Technology Co., Ltd.
K252812 · Decided Jul 31, 2026 · 330 days after receipt
Device type: Device, Vascular, For Promoting Embolization (KRD) · Cardiology
K261488 · Decided Jul 24, 2026 · 79 days after receipt
Device type: Device, Vascular, For Promoting Embolization (KRD) · Cardiology
65 more FDA decisions with a free account
Reports received
1,628
Received Nov 1, 2025 to Nov 19, 2026. Includes 2 of another or unstated type.
Malfunction reports
1,336
82% of reports
Injury reports
278
17% of reports
Death reports
12
0.7% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 97 | 30 | 2 | 0 |
| Jan 24 | 132 | 22 | 2 | 0 |
| Feb 24 | 105 | 20 | 1 | 0 |
| Mar 24 | 104 | 16 | 1 | 0 |
| Apr 24 | 108 | 24 | 2 | 0 |
| May 24 | 105 | 29 | 0 | 0 |
| Jun 24 | 111 | 25 | 0 | 0 |
| Jul 24 | 99 | 31 | 0 | 0 |
| Aug 24 | 85 | 16 | 2 | 0 |
| Sep 24 | 93 | 12 | 7 | 0 |
| Oct 24 | 76 | 30 | 1 | 1 |
| Nov 24 | 113 | 28 | 2 | 0 |
| Dec 24 | 93 | 37 | 2 | 0 |
| Jan 25 | 117 | 17 | 1 | 0 |
| Feb 25 | 85 | 28 | 1 | 0 |
| Mar 25 | 121 | 26 | 1 | 0 |
| Apr 25 | 135 | 30 | 2 | 0 |
| May 25 | 100 | 17 | 0 | 0 |
| Jun 25 | 97 | 24 | 2 | 0 |
| Jul 25 | 128 | 19 | 2 | 0 |
| Aug 25 | 104 | 28 | 0 | 0 |
| Sep 25 | 108 | 31 | 2 | 0 |
| Oct 25 | 113 | 20 | 4 | 0 |
| Nov 25 | 85 | 22 | 0 | 0 |
| Dec 25 | 100 | 25 | 2 | 0 |
| Jan 26 | 118 | 16 | 1 | 0 |
| Feb 26 | 94 | 31 | 0 | 0 |
| Mar 26 | 116 | 18 | 0 | 0 |
| Apr 26 | 154 | 36 | 2 | 0 |
| May 26 | 121 | 15 | 3 | 0 |
| Jun 26 | 138 | 19 | 0 | 0 |
| Jul 26 | 97 | 45 | 4 | 1 |
| Aug 26 | 109 | 21 | 0 | 1 |
| Sep 26 | 111 | 14 | 0 | 0 |
| Oct 26 | 93 | 16 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
7 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Separation Failure301
- Physical Resistance/Sticking290
- Premature Separation256
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions1,430
- Foreign Body In Patient71
- Pain24
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-3305-2026 · Started Aug 10, 2026 · Posted by FDA Sep 25, 2026
Reason given: Microspheres used in embolization of tumors, prostatic arteries, arteriovenous malformations, and blood vessels may have holes in packaging that may affect the sterile barrier, which if used could lead to infection.
Cause as FDA categorized it: Process control
- LIFEPEARL Drug Elutable Microspheres: 200 +/- 50 micrometers, REF: 8LP2S200; 400 +/- 50 micrometers, REF: 8LP2S400Open, Classified
Z-2188-2025 · Started May 29, 2025 · Posted by FDA Jul 28, 2025
Reason given: Drug Elutable Microspheres have a smaller actual average diameter that is not within specification, which may lead to inability to reach the desired treatment location (non-targeted embolization), additional procedure/treatment required, blockage other than target vessel, increased procedure time, incomplete...
Cause as FDA categorized it: Device Design
Z-1989-2025 · Started May 8, 2025 · Posted by FDA Jun 18, 2025
Reason given: Due to radiopaque (RO) marker was not visible during angiography and it was determined that the RO marker was not manufactured to specification.
Cause as FDA categorized it: Vendor change control
17 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.